Postoperative Respiratory and Activity Monitoring

University of Colorado Denver (CU Denver)

Status: Enrolling

Conditions: Postoperative Pulmonary Complications; Hypoventilation; Hypoxemia

Treatments: Device: ExSpiron and ActivPAL Monitors

Study type: Observational

Funder types: Other

Identifiers

NCT06239831

22-2268

Details and patient eligibility

About

This study plans to learn more about specific breathing and activity recommendations for patients after surgery. Participants will be monitored after abdominal surgery to identify what activities help them breathe better and reduce complications after surgery.

Full description

Investigators will study adults undergoing elective abdominal surgery with at least moderate risk for postoperative pulmonary complications.

Participants will be monitored on their chest and thigh with devices that record their breathing pattern (breath volume and frequency) and body position and movements. These monitors will be placed on their skin in the Post-Anesthesia Care Unit (PACU) and will stay on for three days, or until the patient is able to ambulate freely or until their hospital discharge, whichever comes earlier. Investigators will analyze the association between the frequency, duration and intensity of various activities (e.g., sitting, walking) and breathing and other clinical complications, in combination with medications received and other hospital course events.

Enrollment: 30 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must be 18 or older
• Must be undergoing abdominal surgery
• Must be high-risk for PPCs (ARISCAT score equal to or greater than 26)

Exclusion criteria

• Anyone under 18
• Anyone not undergoing abdominal surgery
• Anyone that is not high-risk for PPCs (ARISCAT score less than 26)

Trial design

30 participants in 1 patient group

Postoperative monitoring

Description:

ActivPAL accelerometer will be placed on the chest and thigh, an ExSpiron monitor placed on the chest, and the patient will be observed for three days, until fully ambulatory (able to walk 30 meters without assistance with or without a walker), or until discharge; whichever comes earlier.

Treatment:

Device: ExSpiron and ActivPAL Monitors